KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Guardant Health (GH) Short-term Investments: 2017-2024

Historic Short-term Investments for Guardant Health (GH) over the last 5 years, with Dec 2024 value amounting to $314.4 million.

  • Guardant Health's Short-term Investments rose 795.91% to $314.4 million in Q4 2024 from the same period last year, while for Dec 2024 it was $314.4 million, marking a year-over-year increase of 795.91%. This contributed to the annual value of $314.4 million for FY2024, which is 795.91% up from last year.
  • Latest data reveals that Guardant Health reported Short-term Investments of $314.4 million as of Q4 2024, which was up 1.20% from $310.7 million recorded in Q3 2024.
  • In the past 5 years, Guardant Health's Short-term Investments ranged from a high of $1.1 billion in Q1 2021 and a low of $35.1 million during Q4 2023.
  • In the last 3 years, Guardant Health's Short-term Investments had a median value of $668.0 million in 2022 and averaged $572.1 million.
  • In the last 5 years, Guardant Health's Short-term Investments crashed by 95.96% in 2023 and then spiked by 795.91% in 2024.
  • Guardant Health's Short-term Investments (Quarterly) stood at $961.9 million in 2020, then crashed by 54.20% to $440.5 million in 2021, then soared by 97.39% to $869.6 million in 2022, then tumbled by 95.96% to $35.1 million in 2023, then surged by 795.91% to $314.4 million in 2024.
  • Its Short-term Investments was $314.4 million in Q4 2024, compared to $310.7 million in Q3 2024 and $35.1 million in Q4 2023.